Celularity Inc. Class A Common Stock (CELU) Stock Price, Quote & AI Analysis

Live CELU stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Celularity Inc. Class A Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Celularity Inc. Class A Common Stock (CELU), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

CELU
Celularity Inc. Class A Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
1.020000
High
1.020000
Low
0.850000
Volume
34,252
VWAP
-
Market Cap
$25,249,561.78
52W Range
$0.71 - $4.35
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Celularity Inc. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Celularity Inc. Class A Common Stock Overview

Company information

Company Overview

Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.

Company Details
Market Cap
$25.10M
Shares Outstanding
28,946,000
Weighted Shares Outstanding
28,945,961
CEO
Robert Joseph Hariri Gordon
Address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Employees
115
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Celularity Inc. Class A Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...